ICU Admission and Post-Discharge Mortality in COVID-19: Different Risk Factors Across Clinical Phases
Open Access
- 14 May 2026
- journal article
- research article
- Published by MDPI AG in Medical Sciences
- Vol. 14 (2) , 255
Abstract
Background: Risk factors for severe COVID-19 and in-hospital mortality are well described, but it remains unclear whether the same factors predict mortality after hospital discharge. Distinguishing risk profiles across clinical phases may improve patient management and follow-up strategies. Methods: We conducted a retrospective observational cohort study of 595 adults hospitalized with PCR-confirmed SARS-CoV-2 infection in Portugal (September–November 2020). The primary outcome was all-cause mortality during hospitalization and up to 120 days post-discharge. Secondary outcomes included intensive care unit (ICU) admission, maximum disease severity (WHO Clinical Progression Scale), oxygen supplementation, and length of stay. Univariable and multivariable regression analyses were performed using logistic regression for binary outcomes and linear regression for continuous outcomes. Results: Overall mortality was 22.5%, rising from 14.1% in-hospital to 22.5% at 120-day follow-up (p < 0.001), with 37.3% of deaths occurring post-discharge. ICU admission was required in 17.6% of patients and was significantly associated with obesity (OR = 2.12, 95% CI: 1.39–3.23, p < 0.001) and male sex (OR = 1.78, 95% CI: 1.14–2.78, p = 0.010) in univariable analysis. In contrast, post-discharge mortality was associated with longer hospital stay (18.4 vs. 9.9 days, p < 0.001) and a higher prevalence of malignancy (28.0% vs. 13.1%, p = 0.032), but not with ICU admission. In multivariable logistic regression, oxygen supplementation was the strongest predictor of 120-day mortality (OR = 2.50, 95% CI: 1.38–4.51, p = 0.002). Only pulmonary diseases and obesity were independently associated with maximum disease severity. Conclusions: Risk factors for acute COVID-19 severity differ from those for post-discharge mortality. These findings support a phase-specific approach to risk stratification, suggesting that patients with obesity are at increased risk of early respiratory deterioration, while patients with malignancy may benefit from closer post-discharge follow-up regardless of ICU admission status.Keywords
All Related Versions
This publication has 39 references indexed in Scilit:
- Management and outcomes of children hospitalised with COVID-19 including incidental and nosocomial infections in Australia 2020–2023: A national surveillance studyJournal of Clinical Virology, 2025
- Analysis of six consecutive waves of ICU-admitted COVID-19 patients: key findings and insights from a Portuguese populationGeroScience, 2024
- Impact of the COVID-19 pandemic on cancer screenings in PortugalCancer Epidemiology, 2023
- WHO Ordinal Scale and Inflammation Risk Categories in COVID-19. Comparative Study of the Severity ScalesJournal of General Internal Medicine, 2022
- Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19JAMA Internal Medicine, 2020
- High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical VentilationObesity, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Dopaminergic Pathways in Obesity-Associated InflammationJournal of Neuroimmune Pharmacology, 2019